# Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

> **NCT05827978** · PHASE3 · COMPLETED · sponsor: **ModernaTX, Inc.** · enrollment: 8411 (actual)

## Conditions studied

- Seasonal Influenza

## Interventions

- **BIOLOGICAL:** mRNA-1010
- **BIOLOGICAL:** Licensed Quadrivalent Inactivated Seasonal Influenza Vaccine

## Key facts

- **NCT ID:** NCT05827978
- **Lead sponsor:** ModernaTX, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-17
- **Primary completion:** 2024-06-24
- **Final completion:** 2024-06-24
- **Target enrollment:** 8411 (ACTUAL)
- **Last updated:** 2025-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05827978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05827978, "Study of mRNA-1010 Seasonal Influenza Vaccine in Adults". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05827978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*